← Evidence map

ArticleBiomarker research2025

Development of a bispecific antibody that inhibits EGFR and B7H3 in NSCLC.

Xinxin Zhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41291854